Milrinone Injection Shortage
Last Updated: May 17, 2016
Status: Resolved
Reason for the Shortage
-
- Fresenius Kabi states the reason for the shortage was increased demand for the product.
- Hospira had milrinone injection on shortage due to increased demand.
- West-Ward states the shortage was due to manufacturing delays.
Available Products
-
- Milrinone injection, Baxter, 0.2 mg/mL, 100 mL premixed bag, 10 count, NDC 00338-6010-48
- Milrinone injection, Baxter, 0.2 mg/mL, 200 mL premixed bag, 10 count, NDC 00338-6011-37
- Milrinone injection, Fresenius Kabi, 1 mg/mL, 10 mL vial, 10 count, NDC 63323-0617-10
- Milrinone injection, Fresenius Kabi, 1 mg/mL, 20 mL vial, 10 count, NDC 63323-0617-20
- Milrinone injection, Fresenius Kabi, 1 mg/mL, 50 mL vial, 1 count, NDC 63323-0617-50
- Milrinone injection, Pfizer, 0.2 mg/mL, 100 mL premixed bag, 10 count, NDC 00409-2776-23
- Milrinone injection, Pfizer, 0.2 mg/mL, 200 mL premixed bag, 10 count, NDC 00409-2776-02
- Milrinone injection, Pfizer, 1 mg/mL, 10 mL vial, 10 count, NDC 00409-0212-01
- Milrinone injection, Pfizer, 1 mg/mL, 20 mL vial, 10 count, NDC 00409-0212-02
- Milrinone injection, Pfizer, 1 mg/mL, 50 mL vial, 1 count, NDC 00409-0212-03
- Milrinone injection, West-Ward, 0.2 mg/mL, 100 mL premixed bag, 10 count, NDC 00143-9719-10
- Milrinone injection, West-Ward, 0.2 mg/mL, 200 mL premixed bag, 10 count, NDC 00143-9718-10
- Milrinone injection, West-Ward, 1 mg/mL, 10 mL vial, 10 count, NDC 00143-9710-10
- Milrinone injection, West-Ward, 1 mg/mL, 20 mL vial, 10 count, NDC 00143-9709-10
- Milrinone injection, West-Ward, 1 mg/mL, 50 mL vial, 1 count, NDC 00143-9708-01
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated May 17, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 7, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.